Adaptive deep propagation graph neural network for predicting miRNA–disease associations

• Published in: Briefings in functional genomics Vol. 22; no. 5; pp. 453 - 462
• Main Authors: Hu, Hua, Zhao, Huan, Zhong, Tangbo, Dong, Xishang, Wang, Lei, Han, Pengyong, Li, Zhengwei
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 10.11.2023
• Subjects: deep learning; graph neural networks; propagation; miRNA–disease associations; attention mechanism; heterogeneous graph
• ISSN: 2041-2649; 2041-2657
• DOI: 10.1093/bfgp/elad010

Abstract Background A large number of experiments show that the abnormal expression of miRNA is closely related to the occurrence, diagnosis and treatment of diseases. Identifying associations between miRNAs and diseases is important for clinical applications of complex human diseases. However, traditional biological experimental methods and calculation-based methods have many limitations, which lead to the development of more efficient and accurate deep learning methods for predicting miRNA–disease associations. Results In this paper, we propose a novel model on the basis of adaptive deep propagation graph neural network to predict miRNA–disease associations (ADPMDA). We first construct the miRNA–disease heterogeneous graph based on known miRNA–disease pairs, miRNA integrated similarity information, miRNA sequence information and disease similarity information. Then, we project the features of miRNAs and diseases into a low-dimensional space. After that, attention mechanism is utilized to aggregate the local features of central nodes. In particular, an adaptive deep propagation graph neural network is employed to learn the embedding of nodes, which can adaptively adjust the local and global information of nodes. Finally, the multi-layer perceptron is leveraged to score miRNA–disease pairs. Conclusion Experiments on human microRNA disease database v3.0 dataset show that ADPMDA achieves the mean AUC value of 94.75% under 5-fold cross-validation. We further conduct case studies on the esophageal neoplasm, lung neoplasms and lymphoma to confirm the effectiveness of our proposed model, and 49, 49, 47 of the top 50 predicted miRNAs associated with these diseases are confirmed, respectively. These results demonstrate the effectiveness and superiority of our model in predicting miRNA–disease associations.